Mega%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520cv

# Mega-cv ## Overview Mega-cv is a combination product containing aspirin and a statin medication (e.g., atorvastatin, rosuvastatin). Its exact composition and formulation vary by manufacturer. Aspirin is an antiplatelet agent, and statins are HMG-CoA reductase inhibitors used to lower cholesterol. ## Primary Indications * Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in patients with established cardiovascular disease or at high risk. * Adjunctive therapy for hyperlipidemia. ## Adult Dosing * Dosing is highly variable depending on the specific statin component and its strength. * Aspirin dose typically ranges from 81 mg to 325 mg daily. * Statin doses vary (e.g., atorvastatin 10-80 mg daily, rosuvastatin 5-40 mg daily). * **Consult specific product labeling for exact dosing.** ## Pediatric Dosing * Use in pediatric patients is generally not recommended due to limited data. * Specific indications and dosing, if applicable, would be determined by a specialist. ## Dose Adjustments * **Renal Impairment:** May require dose adjustment or alternative therapy, especially for the statin component. Consult specific product information. * **Hepatic Impairment:** Statins are generally contraindicated or require caution in patients with active liver disease. Aspirin use should also be carefully considered. ## Contraindications * Hypersensitivity to aspirin, statins, or any component of the formulation. * Active peptic ulceration or history of recurrent ulceration. * History of bronchospasm with aspirin. * Active liver disease or unexplained persistent elevations in liver enzymes. * Pregnancy and breastfeeding (statins are generally contraindicated). * Certain bleeding disorders. ## Adverse Effects * **Common:** Gastrointestinal upset, dyspepsia, muscle aches (myalgia), headache. * **Serious:** Gastrointestinal bleeding, liver enzyme elevations, rhabdomyolysis, increased risk of hemorrhagic stroke (particularly with higher aspirin doses), allergic reactions. ## Key Drug Interactions * **Warfarin:** Increased risk of bleeding with aspirin component. * **Other NSAIDs or Anticoagulants:** Additive antiplatelet and anticoagulant effects, increasing bleeding risk. * **CYP3A4 Inhibitors/Inducers:** May affect statin metabolism (e.g., atorvastatin), altering plasma concentrations and risk of side effects. Examples include macrolide antibiotics, azole antifungals, and certain protease inhibitors. * **Gemfibrozil:** Increased risk of myopathy with certain statins. ## Monitoring * Baseline and periodic liver function tests (LFTs). * Lipid panel (cholesterol, triglycerides, LDL, HDL). * Monitor for signs and symptoms of bleeding (e.g., melena, hematemesis, bruising). * Monitor for signs and symptoms of myopathy (e.g., muscle pain, tenderness, weakness). * Renal function may need monitoring depending on patient factors and specific statin. ## Clinical Pearls * This combination product may simplify medication regimens for patients requiring both an antiplatelet and a statin. * Ensure the specific statin and aspirin dose within the combination product align with guideline recommendations and patient needs. * Discontinue if muscle pain, weakness, or liver abnormalities develop. * Aspirin component increases bleeding risk; exercise caution when combining with other agents that affect hemostasis. *** **Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always verify current prescribing information with the official product labeling and consult with a qualified healthcare provider for any medical decisions.